Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Free Cash Flow (2022 - 2025)

Praxis Precision Medicines has reported Free Cash Flow over the past 4 years, most recently at -$76.3 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$76.3 million for Q4 2025, down 36.0% from a year ago — trailing twelve months through Dec 2025 was -$249.1 million (down 89.08% YoY), and the annual figure for FY2025 was -$249.1 million, down 89.08%.
  • Free Cash Flow for Q4 2025 was -$76.3 million at Praxis Precision Medicines, down from -$65.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for PRAX hit a ceiling of -$20.9 million in Q1 2024 and a floor of -$76.3 million in Q4 2025.
  • Median Free Cash Flow over the past 4 years was -$38.7 million (2022), compared with a mean of -$42.3 million.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 47.74% in 2023 and later crashed 154.47% in 2025.
  • Praxis Precision Medicines' Free Cash Flow stood at -$29.2 million in 2022, then rose by 18.42% to -$23.9 million in 2023, then plummeted by 135.2% to -$56.1 million in 2024, then plummeted by 36.0% to -$76.3 million in 2025.
  • The last three reported values for Free Cash Flow were -$76.3 million (Q4 2025), -$65.0 million (Q3 2025), and -$54.7 million (Q2 2025) per Business Quant data.